Epidiolex Advisory Committee Appears To Be Covering US FDA's Bases, But Liver Injury Concerns Persist

 
• By Michael Cipriano
Airliner in flight
It looks like clear skies for GW Pharmaceuticals's childhood epilepsy drug Epidiolex (cannabidiol).

More from US FDA Performance Tracker

More from Regulatory Trackers